A potential vaccine for chlamydia, which infects millions each year, has passed an important early test on the road to availability:
, researchers from Imperial College London compared the effects of two vaccine formulations and one placebo among a group of 35 female participants, none of whom had chlamydia.
The highest rates of infection occur among teens and young adults, and while many patients might not notice signs of chlamydia, it can lead to serious complications if not treated with antibiotics.The potential vaccine is still in the early stages, but if all goes well with testing in the next few years, a chlamydia vaccine could be available in as few as five years, according to Department of Infectious Disease, and the study's co-author.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
The US budget deficit is up 27% and getting closer to $1 trillionThe increase comes a little over a year and a half after the Trump administration ushered through a $1.5 trillion tax cuts that the White House has vowed would pay for itself.
Baca lebih lajut »
A vaccine that may prevent chlamydia is being tested in peopleThe first chlamydia vaccine to be tested in humans shows shown to be safe and may protect against the bacterial infection.
Baca lebih lajut »
Film News Roundup: Djimon Hounsou Replaces Brian Tyree Henry in ‘Quiet Place’ SequelIn today’s film news roundup, Djimon Hounsou fills in for Brian Tyree Henry in the “Quiet Place” sequel, “Toni Morrison: The Pieces I Am” gets a wide release and a Lou…
Baca lebih lajut »
A chlamydia vaccine shows signs of success in an early trialScientists have taken a step towards a vaccine for chlamydia following a successful early trial.
Baca lebih lajut »